Apr. 4 at 6:14 PM
$FBIO Fortress 53% ownership of DERM on the stock exchange is currently worth
$41 M while Fortress itself is only valued at
$34 M. So you get
$7 M plus all these 9 partially owned biotech companies for free in the valuation:
Helocyte – 83%
Callvation – 79%
Oncogenuity – 79%
Cyprium – 74% (Sentynl deal in picture)
Urica – 68%
Caelum – 42% (42% of future proceeds to Caelum from AstraZeneca, up to ~
$150 M in future proceeds)
Aevitas - ? (FBIO is eligible to receive up to ~
$140 million in potential late-stage development, regulatory and sales milestone payments plus royalties from 4DMT)
Mustang – 21%
Avenue – 12%
Checkpoint – 11%
In addition to the ownership percentage, Fortress has a 2.5% annual equity dividend and 4.5% royalty in almost all of these companies.
$XBI $BBH $FBT
